Prudent Man Advisors LLC Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Prudent Man Advisors LLC bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 3rd quarter, Holdings Channel reports. The institutional investor bought 1,760 shares of the biotechnology company’s stock, valued at approximately $703,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Blue Trust Inc. grew its position in shares of Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after buying an additional 79 shares during the last quarter. Quent Capital LLC boosted its stake in Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after acquiring an additional 75 shares in the last quarter. Asset Dedication LLC purchased a new position in shares of Axon Enterprise during the second quarter worth about $47,000. Planning Capital Management Corp increased its position in shares of Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares in the last quarter. Finally, Friedenthal Financial purchased a new stake in shares of Axon Enterprise in the 3rd quarter valued at about $51,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON opened at $599.35 on Monday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 52-week low of $220.78 and a 52-week high of $624.84. The company has a 50-day simple moving average of $438.79 and a 200-day simple moving average of $357.90. The company has a market capitalization of $45.70 billion, a PE ratio of 154.87, a P/E/G ratio of 15.05 and a beta of 0.94.

Insider Buying and Selling at Axon Enterprise

In related news, Director Julie A. Cullivan sold 900 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total value of $318,177.00. Following the sale, the director now owns 3,653 shares in the company, valued at $1,291,445.09. This represents a 19.77 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the sale, the insider now owns 154,394 shares in the company, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 411,006 shares of company stock valued at $161,360,618. Corporate insiders own 6.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on AXON. Craig Hallum raised their price target on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Barclays raised their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Robert W. Baird upped their price target on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Finally, JMP Securities lifted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $427.83.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.